GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Macrogen Inc (XKRX:038290) » Definitions » LT-Debt-to-Total-Asset

Macrogen (XKRX:038290) LT-Debt-to-Total-Asset : 0.07 (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Macrogen LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Macrogen's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.07.

Macrogen's long-term debt to total assets ratio declined from Dec. 2023 (0.12) to Dec. 2024 (0.07). It may suggest that Macrogen is progressively becoming less dependent on debt to grow their business.


Macrogen LT-Debt-to-Total-Asset Historical Data

The historical data trend for Macrogen's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Macrogen LT-Debt-to-Total-Asset Chart

Macrogen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.01 0.11 0.12 0.07

Macrogen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.11 0.03 0.03 0.07

Macrogen LT-Debt-to-Total-Asset Calculation

Macrogen's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )/Total Assets (A: Dec. 2024 )
=22518.582/329660.012
=0.07

Macrogen's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=22518.582/329660.012
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Macrogen  (XKRX:038290) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Macrogen LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Macrogen's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Macrogen Business Description

Traded in Other Exchanges
N/A
Address
Cherry Blossom-ro, 10th Floor, Gasan-dong, World Meridien 1st, Seoul, KOR
Macrogen Inc provides DNA sequencing and genome research services. Its business divisions are sequencing, oligo, microarray, mouse, and bioinformatics. The firm's products and services include DNA, Chip and Genetic Medicine products and Database construction, Genome Research and Bioinformatics analysis system consulting services.

Macrogen Headlines

No Headlines